Abbott, DexCom Settle Patent Disputes on Glucose Monitor Tech

Abbott Laboratories said it’s reached an agreement with DexCom Inc. to settle all pending patent disputes between the rivals over continuous glucose-monitoring products.

No money will change hands, and the deal includes a provision that both sides promise they “will not litigate patent, trade dress, and design rights disputes with each other for the next 10 years,” Abbott said Monday afternoon in a statement.

• DexCom and Abbott granted each other and their affiliates “a worldwide, royalty-free, non-exclusive, fully paid-up license to certain patents and patent applications relating to analyte sensing, including to all the patents asserted in the Litigation,” ...